3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Meningioma
1
Leukemia, Hairy Cell
1
Diabetes Mellitus
1
Brain Neoplasms
1
Interventions
Peripheral Blood Stem Cell Transplantation
12
Rituximab
9
Tacrolimus
8
Mycophenolic Acid
8
fludarabine phosphate
7
Cyclophosphamide
7
Whole-Body Irradiation
6
Cyclosporine
5
Radiotherapy
4
Methotrexate
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Busulfan
4
Antilymphocyte Serum
4
immunotoxin HA22
3
fludarabine
3
Etoposide
3
Dexamethasone
3
Calcium Dobesilate
3
plerixafor
2
merphos
2
Therapeutics
2
Sirolimus
2
Ondansetron
2
Melphalan
2
Ipilimumab
2
Flow Cytometry
2
Diphenhydramine
2
Darbepoetin alfa
2
Cord Blood Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Hairy Cell
×
Verapamil
×
Clear all
NCT04233034
2024-11-27
CLVer
Jaeb Center for Health Research
Phase 3
Completed
113 enrolled
42 charts